Published Date: 08 Mar 2023
New findings show that frequent aspirin use provides protection against ovarian cancer, regardless of a person's genetic risk.
Read Full NewsDr Maurie Markman discusses why smoking cessation remains a critical clinical priority for improving mortality risk in patients with advanced cancer.
Dr George Lundberg explains why treating equity as a banned political buzzword undermines the very foundations of public health and medical care.
Insights from AUA 2026, including anticipated presentations, key takeaways, and how new research in metastatic prostate cancer will affect patient care.
Patients’ experience of pain during birth and ob/gyn procedures may relate to a perceived loss of control or a clinician’s lack of concern.
A small pilot study found that selectively filtering circulating protein sFlt-1 from maternal blood was safe and prolonged pregnancy in women with very preterm preeclampsia.
A new HHS action plan aims to curb psychiatric drug “overprescribing” and expand nonmedication mental health care, drawing criticism from the APA.
The use of nucleic acid synthesis inhibitors or sphingosine-1-phosphate modulators, fumarates, or interferons is linked to a lower risk for noninfectious uveitis in patients with MS, a new study finds.
1.
Tumor infiltration of major blood vessels, not metastasis, may be primary cause of cancer death
2.
Pancreatic Cancer: A Novel CD40 Agonist-Chemo Combo Shows Promise.
3.
Males with early-onset colorectal cancer are at risk, according to a study.
4.
Since 2000, the outlook for multiple myeloma has improved.
5.
New policy review highlights the importance of health-related quality of life in advanced cancer
1.
Carboplatin Treatment: What You Need to Know About Side Effects and Efficacy
2.
Debunking Myths About Systemic Mastocytosis: Separating Fact from Fiction
3.
Understanding Odontogenic Keratocyst: Symptoms, Causes, and Treatments from Dental Experts
4.
Revolutionizing Lung Cancer Treatment: Exploring the Benefits of Wedge Resection Surgery
5.
From Birthmarks to Tumors: The Science Behind Infantile Hemangioma
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
2.
Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV
5.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation